Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Sepsis Alliance Survey of Registered Voters Reveals Agreement Across Party Lines - Antimicrobial Resistance is a Very Real Threat and Support for the PASTEUR Act is High


News provided by

Sepsis Alliance

Nov 22, 2024, 03:11 ET

Share this article

Share toX

Share this article

Share toX


Only 37% of voters were familiar with the term "AMR," while a staggering 44% had no knowledge of it. Once informed about AMR, a staggering 70% perceived AMR as a significant issue, with 80% believing it poses a threat to the entire population.

SAN DIEGO, Calif., Nov. 22, 2024 /PRNewswire-PRWeb/ -- Sepsis Alliance, the nation's first and leading sepsis advocacy organization, conducted a comprehensive survey to gauge registered voters' understanding and opinions on Antimicrobial Resistance (AMR). The findings of this survey will serve as a valuable resource for engaging elected officials, as well as for potential education and advocacy initiatives.

AMR occurs when specific strains of bacteria, viruses, fungi, or parasites that make people sick have adapted in order to avoid the antimicrobials (medicines such as antibiotics, antivirals, antifungals, and antiparasitics) designed to treat them. These drug-resistant germs, also known as superbugs, are currently putting millions of people at risk of developing a life-threatening, untreatable infection. Globally, 4.71 million deaths were associated with bacterial AMR in 2021, and this number is projected to grow substantially into the future.

The broad support for the PASTEUR Act among registered voters, coupled with their expectation that elected officials take responsibility for addressing AMR, provides a promising foundation for future legislative efforts around AMR.

Post this

The primary objectives of this research were to assess voter awareness of AMR, its effects, and preventive measures, as well as to determine the level of reliance on antimicrobial medications and their efficacy. Additionally, the survey aimed to identify whether voters perceive AMR as a current threat and/or growing threat. Furthermore, the study sought to evaluate familiarity with the PASTEUR Act and gauge voters' support for congressional efforts to pass the bill.

The survey revealed that while there is some understanding of the dangers of infections, awareness of AMR and its effects remains low. Only 37% of voters were familiar with the term "AMR," while a staggering 44% had no knowledge of it. Furthermore, of those claiming they are aware, 21% provided incorrect descriptions of AMR. These findings highlight the urgent need for increased education and awareness surrounding this critical issue.

Once informed about AMR, the majority of voters recognized it as a major problem and a potential threat to the population. Across party lines, a staggering 70% perceived AMR as a significant issue (73% of Democrats, 68% of Republicans, and 67% of Independents), with 80% believing it poses a threat to the entire population (82% of Democrats, 78% of Republicans, and 79% of Independents). Moreover, 67% of respondents believed that the AMR problem is escalating. Overuse of antibiotics and failure to complete antibiotic courses were identified as major concerns by approximately 60% of participants. Additionally, around two-thirds expressed worry about the ability to develop new drugs to combat infections.

The survey also shed light on voters' support for the PASTEUR Act and elected officials who champion its passage. The PASTEUR Act is a piece of federal legislation that seeks to slow and stop the growing problem of AMR by encouraging the development of new drugs and protecting the ones we already have, ensuring that medications continue to work effectively against infectious germs. While initial awareness of the bill was low, with only 18% somewhat or very familiar with it, an overwhelming 90% of respondents expressed support for the PASTEUR Act after learning more about it (94% of Democrats, 87% of Republicans, and 88% of Independents). Impressively, there was high bipartisan agreement, with 86% of voters claiming they would back a Congress member working towards passing the bill. Notably, supporters of the PASTEUR Act were significantly more likely to hold elected officials responsible for addressing AMR than those who did not support the PASTEUR Act.

The broad support for the PASTEUR Act among registered voters, coupled with their expectation that elected officials take responsibility for addressing AMR, provides a promising foundation for future legislative efforts around AMR.

Finally, a significant challenge identified by the survey is the improper use of antimicrobials. A considerable proportion of voters either failed to complete the full course of prescribed antibiotics or experienced initial treatment failure, necessitating additional medications. In the past 12 months, 21% of respondents personally took antimicrobials, and 14% had a loved one who required them. Alarmingly, 10% of those who initiated antimicrobial treatment did not complete the full course, and more than 1 in 10 experienced treatment failure with their initial prescription.

The survey was conducted by Radius Global Market Research on behalf of Sepsis Alliance. among 2,021 registered voters, representative of the U.S. Census for age, gender, region, race/ethnicity, and income.

For more information on the survey findings and Sepsis Alliance's ongoing initiatives to combat AMR, please visit EndSuperbugs.org.

Funding for this survey was provided through a grant from PhRMA.

Click here to access the full report.

Click here to access additional AMR information and educational materials.

Media Contact

Alexandria Colvin, Sepsis Alliance, 1 6192320300, [email protected], www.sepsis.org

SOURCE Sepsis Alliance; Sepsis Alliance

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.